# China NMPA Drug Inspection - Luoyang Yilong Pharmaceutical Co., Ltd. - Angelica sinensis slices

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/luoyang-yilong-pharmaceutical-co-ltd/6158217c-8b8e-40ab-a9bb-41d4fce9bcc8/
Source feed: China

> China NMPA drug inspection for Luoyang Yilong Pharmaceutical Co., Ltd. published March 25, 2020. Drug: Angelica sinensis slices. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 1, 2020)
- Company Name: Luoyang Yilong Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-25
- Drug Name: Angelica sinensis slices
- Inspection Finding: [Check] Disintegration time limit
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/luoyang-yilong-pharmaceutical-co-ltd/75f7dd4e-9877-4265-9d58-bf8ef8bdbe90/